Clinical trials are crucial for developing new treatments and interventions for neonatal disorders. These trials must adhere to strict ethical and regulatory standards to protect the vulnerable neonatal population. Institutional Review Boards (IRBs) review and approve clinical research involving neonates to ensure compliance with ethical guidelines.
